US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kairos Pharma, Ltd.

1.65

-0.0300-1.79%

Post-market: 1.690.0400+2.42%19:56 EDT

Volume:77.56K

Turnover:126.64K

Market Cap:5.59M

PE:-0.85

High:1.85

Open:1.72

Low:1.52

Close:1.68

52wk High:14.77

52wk Low:1.52

Shares:3.39M

Float Shares:1.69M

Volume Ratio:1.31

T/O Rate:4.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9469

EPS(LYR):-2.0691

ROE:-113.96%

ROA:-66.91%

PB:1.33

PE(LYR):-0.80

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)

Kairos Pharma Q1 net loss widens to $1.65 million; no revenue

Kairos Pharma announces annual shareholder meeting

Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Actinium Pharmaceuticals (ATNM)

Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate

Benzinga Earnings

Kairos Pharma FY25 net loss widens to $5.4 million; no revenue

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)

Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy

Kairos Pharma Signs Binding Deal to Acquire Worldwide Rights to CL-273

Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to Cl-273 From Orbimed and Torrey Pines Investment-Backed Celyn Therapeutics

THOMSON REUTERS

Kairos Pharma Ltd - to Buy Cl-273 From Celyn Therapeutics

THOMSON REUTERS

BRIEF-Kairos Pharma Announces Signing Of Term Sheet For Strategic Asset Acquisition

Kairos Pharma signs term sheet to acquire CL-273 and CL-741 from Celyn Therapeutics

Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets From Celyn Therapeutics

THOMSON REUTERS

Kairos Pharma Ltd - to Buy Rights to Cl-273 and Cl-741

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/KAPA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KAPA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":1.65,"timestamp":1788292800000,"preClose":1.68,"halted":0,"volume":77563,"hourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.65,"latestTime":"19:56 EDT","volume":7652,"amount":12809.4014,"timestamp":1788306999459,"change":0.04,"changeRate":0.024242,"amplitude":0.048485},"delay":0,"changeRate":-0.017857142857142873,"floatShares":1687757,"shares":3385383,"eps":-1.946945,"marketStatus":"Closed","change":-0.03,"latestTime":"09-01 16:00:00 EDT","open":1.72,"high":1.8499,"low":1.52,"amount":126643.49353489999,"amplitude":0.196369,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.946945,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":5,"adr":0,"listingDate":1717992000000,"exchange":"AMEX","adjPreClose":1.68,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":1.68,"latestTime":"09:26 EDT","volume":1542,"amount":2674.3680084,"timestamp":1788269217452,"change":0.06,"changeRate":0.035714,"amplitude":0.154107},"postHourTrading":{"tag":"盘后","latestPrice":1.69,"preClose":1.65,"latestTime":"19:56 EDT","volume":7652,"amount":12809.4014,"timestamp":1788306999459,"change":0.04,"changeRate":0.024242,"amplitude":0.048485},"volumeRatio":1.309982},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","floatShares":1687757,"roa":"-66.91%","roe":"-113.96%","lyrEps":-2.069102,"volumeRatio":1.309982,"shares":3385383,"dividePrice":0,"high":1.8499,"amplitude":0.196369,"preClose":1.68,"low":1.52,"week52Low":1.52,"pbRate":"1.33","week52High":14.77,"institutionHeld":0,"latestPrice":1.65,"eps":-1.946945,"divideRate":0,"volume":77563,"delay":0,"ttmEps":-1.946945,"open":1.72,"prevYearClose":4.97,"prevWeekClose":1.6597,"prevMonthClose":1.68,"prevQuarterClose":2.6859,"fiveDayClose":1.7374,"twentyDayClose":2.2764,"sixtyDayClose":3.08},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KAPA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-09-01","symbol":"KAPA","defaultRemindTime":1788269400000,"type":"split","dateTimestamp":1788235200000,"forFactor":7,"toFactor":1,"ratio":7}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KAPA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KAPA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1743739200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KAPA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KAPA","date":"2026-08-31","current":-0.847482,"percent":0.997955,"low":-25.607053,"twenty":-6.936607,"median":-3.997823,"eighty":-2.329249,"high":-0.947091,"avg":-4.619083,"sd":3.023849,"marketCap":5618720},"quantilePoints":[{"date":"2024-09-13","current":-25.607053,"twenty":-25.607053,"median":-25.607053,"eighty":-25.607053,"marketCap":51367748},{"date":"2024-09-20","current":-14.59602,"twenty":-25.607053,"median":-16.196461,"eighty":-14.724055,"marketCap":29279616},{"date":"2024-09-27","current":-10.594918,"twenty":-16.644584,"median":-14.59602,"eighty":-12.803526,"marketCap":21253405},{"date":"2024-10-04","current":-8.706398,"twenty":-15.748337,"median":-12.835535,"eighty":-9.858715,"marketCap":17465034},{"date":"2024-10-11","current":-9.410592,"twenty":-14.724055,"median":-10.594918,"eighty":-8.706398,"marketCap":18877647},{"date":"2024-10-18","current":-9.410592,"twenty":-14.59602,"median":-9.890724,"eighty":-9.026486,"marketCap":18877647},{"date":"2024-10-25","current":-9.602645,"twenty":-14.019861,"median":-9.73068,"eighty":-9.026486,"marketCap":19262905},{"date":"2024-10-31","current":-8.64238,"twenty":-13.098007,"median":-9.602645,"eighty":-8.947104,"marketCap":17336614},{"date":"2024-11-08","current":-8.770415,"twenty":-12.81633,"median":-9.464686,"eighty":-8.64238,"marketCap":17593453},{"date":"2024-11-15","current":-13.158824,"twenty":-13.152678,"median":-9.474609,"eighty":-8.64238,"marketCap":26396601},{"date":"2024-11-22","current":-7.030345,"twenty":-12.924264,"median":-9.410592,"eighty":-8.578362,"marketCap":19270177},{"date":"2024-11-29","current":-7.217821,"twenty":-12.829133,"median":-9.282556,"eighty":-8.469532,"marketCap":19784048},{"date":"2024-12-06","current":-6.608525,"twenty":-12.265778,"median":-9.026486,"eighty":-7.967725,"marketCap":18113966},{"date":"2024-12-13","current":-8.061463,"twenty":-11.119862,"median":-8.738406,"eighty":-7.667763,"marketCap":22096470},{"date":"2024-12-20","current":-7.920856,"twenty":-10.268428,"median":-8.706398,"eighty":-7.780249,"marketCap":21711066},{"date":"2024-12-27","current":-7.827118,"twenty":-9.999554,"median":-8.64238,"eighty":-7.780249,"marketCap":21454130},{"date":"2025-01-03","current":-7.170953,"twenty":-9.909929,"median":-8.578362,"eighty":-7.46154,"marketCap":19655581},{"date":"2025-01-10","current":-4.827504,"twenty":-9.858715,"median":-8.578362,"eighty":-7.311559,"marketCap":13232188},{"date":"2025-01-17","current":-8.295808,"twenty":-9.858715,"median":-8.530349,"eighty":-7.261949,"marketCap":22738809},{"date":"2025-01-24","current":-7.311559,"twenty":-9.756287,"median":-8.373067,"eighty":-7.264142,"marketCap":20040984},{"date":"2025-01-31","current":-6.936607,"twenty":-9.73068,"median":-8.108332,"eighty":-7.170953,"marketCap":19013241},{"date":"2025-02-07","current":-6.749132,"twenty":-9.628252,"median":-8.036517,"eighty":-7.161579,"marketCap":18499370},{"date":"2025-02-14","current":-6.796001,"twenty":-9.602645,"median":-7.967725,"eighty":-7.030345,"marketCap":18627838},{"date":"2025-02-21","current":-6.233573,"twenty":-9.526207,"median":-7.967725,"eighty":-7.030345,"marketCap":17086224},{"date":"2025-02-28","current":-5.671145,"twenty":-9.474865,"median":-7.897422,"eighty":-6.869431,"marketCap":15544609},{"date":"2025-03-07","current":-5.198227,"twenty":-9.462702,"median":-7.803684,"eighty":-6.730384,"marketCap":14248340},{"date":"2025-03-14","current":-4.773372,"twenty":-9.428261,"median":-7.780249,"eighty":-6.44917,"marketCap":13083812},{"date":"2025-03-21","current":-4.898329,"twenty":-9.410592,"median":-7.639642,"eighty":-6.289816,"marketCap":13426320},{"date":"2025-03-28","current":-4.848346,"twenty":-9.33377,"median":-7.452166,"eighty":-6.092966,"marketCap":13289317},{"date":"2025-04-04","current":-4.698397,"twenty":-9.282556,"median":-7.358428,"eighty":-5.577408,"marketCap":12878307},{"date":"2025-04-11","current":-4.948312,"twenty":-9.244146,"median":-7.311559,"eighty":-5.297393,"marketCap":13563323},{"date":"2025-04-17","current":-4.775903,"twenty":-9.141718,"median":-7.263319,"eighty":-5.121191,"marketCap":12431676},{"date":"2025-04-25","current":-5.470376,"twenty":-9.018804,"median":-7.217821,"eighty":-5.172643,"marketCap":14239390},{"date":"2025-05-02","current":-5.034285,"twenty":-8.912535,"median":-7.170953,"eighty":-5.172643,"marketCap":13104245},{"date":"2025-05-09","current":-4.841892,"twenty":-8.744808,"median":-7.124084,"eighty":-5.140524,"marketCap":12603446},{"date":"2025-05-16","current":-2.898471,"twenty":-8.706398,"median":-7.030345,"eighty":-5.053706,"marketCap":10266383},{"date":"2025-05-23","current":-2.643971,"twenty":-8.706398,"median":-7.030345,"eighty":-4.968305,"marketCap":9364944},{"date":"2025-05-30","current":-2.626341,"twenty":-8.693594,"median":-6.936607,"eighty":-4.902727,"marketCap":9302501},{"date":"2025-06-06","current":-2.390394,"twenty":-8.64238,"median":-6.865004,"eighty":-4.843183,"marketCap":8466776},{"date":"2025-06-13","current":-2.711492,"twenty":-8.629576,"median":-6.796001,"eighty":-4.780395,"marketCap":9604104},{"date":"2025-06-20","current":-2.911286,"twenty":-8.578362,"median":-6.702263,"eighty":-4.758377,"marketCap":10311775},{"date":"2025-06-27","current":-3.282332,"twenty":-8.578362,"median":-6.467918,"eighty":-4.698397,"marketCap":11626021},{"date":"2025-07-03","current":-3.096809,"twenty":-8.578362,"median":-6.421049,"eighty":-4.598431,"marketCap":10968898},{"date":"2025-07-11","current":-3.382229,"twenty":-8.578362,"median":-6.327311,"eighty":-4.315248,"marketCap":11979856},{"date":"2025-07-18","current":-4.852143,"twenty":-8.578362,"median":-6.210138,"eighty":-4.078861,"marketCap":17186292},{"date":"2025-07-25","current":-4.424013,"twenty":-8.501541,"median":-6.156578,"eighty":-4.315248,"marketCap":15669854},{"date":"2025-08-01","current":-4.281779,"twenty":-8.456729,"median":-5.830571,"eighty":-4.144691,"marketCap":15166060},{"date":"2025-08-08","current":-4.566723,"twenty":-8.326712,"median":-5.698056,"eighty":-4.256377,"marketCap":16175333},{"date":"2025-08-15","current":-5.460044,"twenty":-8.265781,"median":-5.577408,"eighty":-4.144691,"marketCap":25722268},{"date":"2025-08-22","current":-5.151816,"twenty":-8.175816,"median":-5.56016,"eighty":-4.256377,"marketCap":24270205},{"date":"2025-08-29","current":-5.548109,"twenty":-8.117706,"median":-5.504045,"eighty":-4.350727,"marketCap":26137143},{"date":"2025-09-05","current":-6.825055,"twenty":-8.080211,"median":-5.554134,"eighty":-4.371339,"marketCap":32152835},{"date":"2025-09-12","current":-7.925871,"twenty":-8.146034,"median":-5.577408,"eighty":-4.403843,"marketCap":37338777},{"date":"2025-09-19","current":-5.90037,"twenty":-8.123413,"median":-5.684601,"eighty":-4.424013,"marketCap":27796645},{"date":"2025-09-26","current":-5.019718,"twenty":-8.080211,"median":-5.577408,"eighty":-4.452555,"marketCap":23647892},{"date":"2025-10-03","current":-5.063751,"twenty":-8.031527,"median":-5.554134,"eighty":-4.485854,"marketCap":23855329},{"date":"2025-10-10","current":-5.812305,"twenty":-7.985263,"median":-5.56016,"eighty":-4.525921,"marketCap":27381769},{"date":"2025-10-17","current":-5.151816,"twenty":-7.967725,"median":-5.531688,"eighty":-4.55855,"marketCap":24270205},{"date":"2025-10-24","current":-4.799555,"twenty":-7.967725,"median":-5.492822,"eighty":-4.58125,"marketCap":22610703},{"date":"2025-10-31","current":-5.019718,"twenty":-7.967725,"median":-5.46521,"eighty":-4.595432,"marketCap":23647892},{"date":"2025-11-07","current":-3.830837,"twenty":-7.967725,"median":-5.399832,"eighty":-4.525921,"marketCap":18047075},{"date":"2025-11-14","current":-3.48298,"twenty":-7.942613,"median":-5.371979,"eighty":-4.424013,"marketCap":16408318},{"date":"2025-11-21","current":-2.82458,"twenty":-7.922862,"median":-5.327946,"eighty":-4.230974,"marketCap":14298023},{"date":"2025-11-28","current":-3.42923,"twenty":-7.902108,"median":-5.296194,"eighty":-4.097795,"marketCap":17358761},{"date":"2025-12-05","current":-3.740193,"twenty":-7.855239,"median":-5.283914,"eighty":-3.903739,"marketCap":18932856},{"date":"2025-12-12","current":-3.331745,"twenty":-7.817744,"median":-5.203591,"eighty":-3.780288,"marketCap":16865295},{"date":"2025-12-19","current":-3.187781,"twenty":-7.79431,"median":-5.197038,"eighty":-3.655562,"marketCap":16136548},{"date":"2025-12-26","current":-3.052866,"twenty":-7.780249,"median":-5.190491,"eighty":-3.531486,"marketCap":15453608},{"date":"2026-01-02","current":-2.920419,"twenty":-7.780249,"median":-5.153702,"eighty":-3.48298,"marketCap":14783160},{"date":"2026-01-09","current":-3.989868,"twenty":-7.780249,"median":-5.151816,"eighty":-3.42923,"marketCap":20196712},{"date":"2026-01-16","current":-3.660807,"twenty":-7.780249,"median":-5.14469,"eighty":-3.42923,"marketCap":18531004},{"date":"2026-01-23","current":-3.208347,"twenty":-7.755842,"median":-5.119133,"eighty":-3.42923,"marketCap":16240655},{"date":"2026-01-30","current":-2.734499,"twenty":-7.661662,"median":-5.098261,"eighty":-3.381278,"marketCap":13842035},{"date":"2026-02-06","current":-2.426827,"twenty":-7.586816,"median":-5.063751,"eighty":-3.364521,"marketCap":12284598},{"date":"2026-02-13","current":-2.442869,"twenty":-7.51395,"median":-5.063751,"eighty":-3.27767,"marketCap":12365801},{"date":"2026-02-20","current":-2.303429,"twenty":-7.470914,"median":-5.048278,"eighty":-3.204892,"marketCap":11659957},{"date":"2026-02-27","current":-2.271757,"twenty":-7.452166,"median":-5.027001,"eighty":-3.156747,"marketCap":11499633},{"date":"2026-03-06","current":-2.698302,"twenty":-7.424045,"median":-5.019718,"eighty":-3.093003,"marketCap":13658807},{"date":"2026-03-13","current":-2.46796,"twenty":-7.400606,"median":-4.98699,"eighty":-3.049512,"marketCap":12492811},{"date":"2026-03-20","current":-2.529659,"twenty":-7.374048,"median":-4.948312,"eighty":-3.027281,"marketCap":12805132},{"date":"2026-03-27","current":-2.419423,"twenty":-7.358428,"median":-4.925987,"eighty":-2.995692,"marketCap":12247119},{"date":"2026-04-02","current":-2.380758,"twenty":-7.33968,"median":-4.899021,"eighty":-2.954226,"marketCap":12051399},{"date":"2026-04-10","current":-2.200475,"twenty":-7.311559,"median":-4.852143,"eighty":-2.923199,"marketCap":11985988},{"date":"2026-04-17","current":-2.403699,"twenty":-7.292811,"median":-4.845967,"eighty":-2.911648,"marketCap":13092947},{"date":"2026-04-24","current":-2.628935,"twenty":-7.263594,"median":-4.843588,"eighty":-2.858198,"marketCap":14319809},{"date":"2026-05-01","current":-2.220915,"twenty":-7.244298,"median":-4.831805,"eighty":-2.782532,"marketCap":12097326},{"date":"2026-05-08","current":-2.180035,"twenty":-7.217821,"median":-4.799555,"eighty":-2.739123,"marketCap":11874650},{"date":"2026-05-15","current":-1.805229,"twenty":-7.199074,"median":-4.787133,"eighty":-2.720186,"marketCap":10540732},{"date":"2026-05-22","current":-2.027078,"twenty":-7.170953,"median":-4.758877,"eighty":-2.696512,"marketCap":11836110},{"date":"2026-05-29","current":-1.932471,"twenty":-7.170953,"median":-4.74838,"eighty":-2.638077,"marketCap":11283701},{"date":"2026-06-05","current":-1.708789,"twenty":-7.161579,"median":-4.699647,"eighty":-2.62783,"marketCap":9977618},{"date":"2026-06-12","current":-1.680187,"twenty":-7.124084,"median":-4.685648,"eighty":-2.591975,"marketCap":9810610},{"date":"2026-06-18","current":-1.675786,"twenty":-7.124084,"median":-4.679404,"eighty":-2.58889,"marketCap":9784917},{"date":"2026-06-26","current":-1.374365,"twenty":-7.089251,"median":-4.661863,"eighty":-2.57116,"marketCap":8024917},{"date":"2026-07-02","current":-1.349796,"twenty":-7.079622,"median":-4.616471,"eighty":-2.529659,"marketCap":7881461},{"date":"2026-07-10","current":-1.356764,"twenty":-7.039719,"median":-4.598431,"eighty":-2.499514,"marketCap":7922143},{"date":"2026-07-17","current":-1.246389,"twenty":-7.030345,"median":-4.556506,"eighty":-2.476269,"marketCap":7277666},{"date":"2026-07-24","current":-1.092378,"twenty":-7.030345,"median":-4.471583,"eighty":-2.464669,"marketCap":6378395},{"date":"2026-07-31","current":-1.099712,"twenty":-7.030345,"median":-4.424013,"eighty":-2.432997,"marketCap":6421218},{"date":"2026-08-07","current":-1.430102,"twenty":-7.030345,"median":-4.370776,"eighty":-2.403935,"marketCap":8350367},{"date":"2026-08-14","current":-1.327826,"twenty":-6.98643,"median":-4.154767,"eighty":-2.384707,"marketCap":7708031},{"date":"2026-08-21","current":-1.204683,"twenty":-6.944825,"median":-4.098893,"eighty":-2.357708,"marketCap":6993186},{"date":"2026-08-28","current":-0.983831,"twenty":-6.936607,"median":-4.005778,"eighty":-2.333263,"marketCap":5711141},{"date":"2026-08-31","current":-0.96791,"twenty":-6.936607,"median":-3.997823,"eighty":-2.329249,"marketCap":5618720}],"updateTime":1788314238361},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KAPA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635741674","title":"Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635741674","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635741674?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:50","pubTimestamp":1778773845,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kairos-pharma-ltd-kapa-integra-lifesciences-iart-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-kairos-pharma-ltd-kapa-integra-lifesciences-iart-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","IART","XBI","BK4581","LU0234570918.USD","LU0320765992.SGD","BK4137","BK4533","XLV","LU0128526141.USD","KAIR","BIIB","BK4139","BK4585","LU0029874061.USD","IE00B894F039.SGD","LU0889565916.HKD","BK4082","IE00B19Z9P08.USD","BK4588","BK4532","IE00B19Z9Z06.USD","HCSG","KAPA","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635633759","title":"Kairos Pharma Q1 net loss widens to $1.65 million; no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2635633759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635633759?lang=en_us&edition=fundamental","pubTime":"2026-05-14 05:22","pubTimestamp":1778707323,"startTime":"0","endTime":"0","summary":"Kairos Pharma posted a net loss of $1.65 million for the quarter ended March 31, 2026, widening from $1.26 million a year earlier.Operating loss widened to $1.69 million as operating expenses climbed to $1.69 million from $1.27 million.Research and development spending rose to $684,000 from $493,000, while general and administrative costs increased to $1.01 million from $773,000.Company raised $385,000 in gross proceeds from an at-the-market offering, signed a manufacturing services agreement with Patheon committing $783,000, and expanded its Lonza work scope by about $2 million for ENV105 Phase II supply preparation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL5V2k1k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU0316494557.USD","LU2764262908.HKD","BK4548","LU1064131342.USD","LU1623119135.USD","LU2211814178.USD","LU0320765489.SGD","LU2041044095.USD","LU1923622614.USD","LU1791710400.SGD","IE0002141913.USD","LU2764263203.CNY","LU0070302665.USD","IE00BQXX3F31.USD","IE00BJJMRZ35.SGD","LU0342679015.USD","LU1023059063.AUD","LU1983299246.USD","LU2125910179.SGD","LU0234572021.USD","LU1720051017.SGD","KAPA","LU2125909759.SGD","LU1815333072.USD","BK4581","LU0823416689.USD","IE00BQXX3D17.EUR","LU1923622291.USD","LU2125910336.SGD","LU0640476718.USD","TMO","LU1548497426.USD","LU0528227936.USD","LU2360108059.USD","LU2357305700.SGD","GB00BDT5M118.USD","LU1989771016.USD","IE00B1BXHZ80.USD","LU1720051108.HKD","BK4533","IE0009355771.USD","IE00B19Z9505.USD","LU2543165471.USD","IE00B2B36J28.USD","LU2092937221.SGD","LU2298321311.HKD","LU1854104046.USD","LU1670628061.USD","LU1633808545.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634462535","title":"Kairos Pharma announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634462535","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634462535?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:30","pubTimestamp":1778272254,"startTime":"0","endTime":"0","summary":"Kairos Pharma scheduled Annual Meeting of Shareholders to be held virtually on June 29, 2026.Meeting materials expected to be finalized and filed with SEC ahead of distribution to shareholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via Business Wire  on May 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL6nLCdk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634462371","title":"Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings","url":"https://stock-news.laohu8.com/highlight/detail?id=2634462371","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634462371?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:30","pubTimestamp":1778272201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA3DQ6V5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624658407","title":"Analysts Are Bullish on Top Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Actinium Pharmaceuticals (ATNM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624658407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624658407?lang=en_us&edition=fundamental","pubTime":"2026-04-03 15:10","pubTimestamp":1775200225,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Kairos Pharma, Ltd. (KAPA) and Actinium Pharmaceutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-kairos-pharma-ltd-kapa-actinium-pharmaceuticals-atnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-kairos-pharma-ltd-kapa-actinium-pharmaceuticals-atnm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSX","BLSG","ATNM","BK4137","KAPA","XBI","BK4112","BK4581","BK4585","BK4139","LU0128526141.USD","LU0029874061.USD","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624355993","title":"Kairos Pharma Q4 EPS $(0.07) Beats $(0.10) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2624355993","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624355993?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:37","pubTimestamp":1774996678,"startTime":"0","endTime":"0","summary":"Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51587940/kairos-pharma-q4-eps-0-07-beats-0-10-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAIR","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624953741","title":"Kairos Pharma FY25 net loss widens to $5.4 million; no revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2624953741","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624953741?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:12","pubTimestamp":1774987956,"startTime":"0","endTime":"0","summary":"Kairos Pharma reported a net loss of $5.4 million, more than doubled from the prior year.Operating loss widened to $5.6 million as total operating expenses climbed to $5.6 million.Research and development expense jumped to $2.1 million due to its Phase 2 prostate cancer trial beginning in 2024.Cash and short-term investments totaled $4.5 million; management said existing cash may not fund planned expenses for at least the next 12 months.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsib","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbgTZZp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618949521","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kairos Pharma, Ltd. (KAPA), Pfizer (PFE) and Medtronic (MDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2618949521","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618949521?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:00","pubTimestamp":1773226813,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Kairos Pharma, Ltd. (KAPA – Research Report), Pfizer (PFE – Resea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kairos-pharma-ltd-kapa-pfizer-pfe-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-kairos-pharma-ltd-kapa-pfizer-pfe-and-medtronic-mdt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","LU0289739699.SGD","BK4592","LU0265550359.USD","LU0321505439.SGD","XBI","LU0058720904.USD","BK4568","LU0072461881.USD","IE00BQXX3D17.EUR","IE0002270589.USD","LU2089984988.USD","IE00BDGV0183.EUR","IE00BQXX3C00.GBP","KAPA","SG9999011175.SGD","BK4550","IE00B19Z3B42.SGD","LU0122379950.USD","LU1116320901.HKD","LU1989771016.USD","LU1989764748.USD","IE00B3PB1722.GBP","LU2089284900.SGD","LU0985481810.HKD","SG9999001176.SGD","LU0128526141.USD","LU0158827948.USD","LU0321505868.SGD","LU1116320737.USD","LU1061106388.HKD","LU0158827781.USD","IE00B3T34201.USD","IE00B42XCP33.USD","BK4007","LU1066051498.USD","LU2089283258.USD","PFE","LU2271345857.HKD","LU1244550577.SGD","SG9999001176.USD","BK4581","IE00BBT3K403.USD","LU0868494617.USD","LU0225284248.USD","LU0456855351.SGD","BK4566","LU0265550946.USD","SG9999003800.SGD","IE00BQXX3F31.USD","LU1244550494.USD","BK4137","SG9999013999.USD","LU2023251221.USD","LU0029874061.USD","LU0170899867.USD","BK4585","LU1883839398.USD","BK4534","LU1506573853.SGD","LU0320765489.SGD","LU1066053197.SGD","IE00BLSP4239.USD","BK4139","LABU","LU0211326755.USD","LU0432979614.USD","LU0306806265.USD","LU1057294990.SGD","LU2111349929.HKD","LU1023059063.AUD","SG9999002232.USD","LU1894683348.USD","BK4588","IE00BFXG1179.USD","IE00BVYPNW00.USD","LU0496365809.HKD","LU0306807586.USD","LU0208291251.USD","LU0225771236.USD","LU2112291526.USD","SGXZ57979304.SGD","LU2468319806.SGD","LU1244550221.USD","LU0314106906.USD","MDT","IE00BGHQF631.EUR","SG9999002224.SGD","BK4599","LU0211326839.USD","IE000M9KFDE8.USD","LU0211331839.USD","LU0976567544.SGD","IE00B19Z3581.USD","LU0162691827.USD","LU1571399168.USD","LU1989764664.SGD","LU0070302665.USD","LU2028103732.USD","LU1894683264.USD","IE00BLSP4452.SGD","IE00BVYPNV92.GBP","LU0234572021.USD","LU1291159041.SGD","BK4533","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616331039","title":"Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2616331039","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616331039?lang=en_us&edition=fundamental","pubTime":"2026-03-02 20:19","pubTimestamp":1772453953,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. ( ($KAPA) ) has shared an announcement. On March 2, 2026, Kairos Pharma, Ltd. entered into a binding term sheet to acquire from...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-acquires-rights-to-ai-discovered-egfr-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kairos-pharma-acquires-rights-to-ai-discovered-egfr-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KAIR","KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616433652","title":"Kairos Pharma Signs Binding Deal to Acquire Worldwide Rights to CL-273","url":"https://stock-news.laohu8.com/highlight/detail?id=2616433652","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616433652?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:30","pubTimestamp":1772451023,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. said it has signed binding terms to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics, a company backed by OrbiMed and Torrey Pines Investment. Kairos said CL-273 is an investigational, AI-designed, reversible, wild-type-sparing pan-EGFR inhibitor aimed at addressing resistance in EGFR-mutant non-small cell lung cancer, and that the deal is expected to be value-accretive. D. Boral Capital acted as sole financial advisor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kairos Pharma Ltd. published the original content used to generate this news brief via Business Wire  on March 02, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL7DfYcJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616363563","title":"Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to Cl-273 From Orbimed and Torrey Pines Investment-Backed Celyn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616363563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616363563?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:30","pubTimestamp":1772451000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA7CPH7L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616336545","title":"Kairos Pharma Ltd - to Buy Cl-273 From Celyn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2616336545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616336545?lang=en_us&edition=fundamental","pubTime":"2026-03-02 19:30","pubTimestamp":1772451000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nTUA7CPH7L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614046044","title":"BRIEF-Kairos Pharma Announces Signing Of Term Sheet For Strategic Asset Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2614046044","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614046044?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:23","pubTimestamp":1772108582,"startTime":"0","endTime":"0","summary":"BRIEF-Kairos Pharma Announces Signing Of Term Sheet For Strategic Asset AcquisitionFeb 26 (Reuters) - Kairos Pharma Ltd KAPA.A:KAIROS PHARMA, LTD. ANNOUNCES SIGNING OF TERM SHEET FOR STRATEGIC ASSET A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA54JRGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045132","title":"Kairos Pharma signs term sheet to acquire CL-273 and CL-741 from Celyn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045132","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045132?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:01","pubTimestamp":1772107284,"startTime":"0","endTime":"0","summary":"Kairos Pharma Ltd. signed a term sheet to acquire worldwide rights from Celyn Therapeutics to two clinical-stage oncology assets for non-small cell lung cancer: CL-273, a pre-IND reversible wild-type-sparing pan-EGFR inhibitor, and CL-741, a Phase 1-ready oral type IIb c-MET inhibitor. The company said the proposed acquisition would expand its pipeline and support development of potential EGFR and MET combination therapy aimed at overcoming resistance in EGFR-mutant NSCLC.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL1gbj5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614456530","title":"Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets From Celyn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2614456530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614456530?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:00","pubTimestamp":1772107202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA54JRGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614045669","title":"Kairos Pharma Ltd - to Buy Rights to Cl-273 and Cl-741","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045669","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045669?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:00","pubTimestamp":1772107202,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA54JRGL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KAPA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}